AEye updates auditor consent on shelf plan

AEye, Inc. filed an exhibits-only S-3 amendment to add an updated KPMG auditor consent while leaving all prior shelf registration terms unchanged.

Rhea-AI Filing Summary

AEye, Inc. (LIDR) filed Amendment No. 1 to its shelf registration statement on Form S-3 (File No. 333-296038) as an exhibits-only update. The amendment primarily files an updated KPMG LLP auditor consent as Exhibit 23.1 and leaves the remainder of the registration statement unchanged.

The company states that effectiveness of the registration statement will be delayed until a further amendment expressly provides for it or until effectiveness is determined under Section 8(a) of the Securities Act.

Filing Explained

No immediate share issuance occurs; the pending registration leaves a conditional 350,000-share warrant-related issuance path.

This amendment updates registration paperwork while effectiveness remains delayed, so it does not itself sell or issue shares.

The underlying shelf covers resale of up to 350,000 common shares issuable upon exercise of the IGEP warrant; resale proceeds would go to the selling holder, while exercise may provide cash to AEye.

If all warrant shares are issued, the supplied records show the share count would increase from 39,943,121 to 40,293,121, creating the dilution associated with additional shares.

As of September 11, 2026, the shelf is recorded as not effective and unused; the state-changing milestones are effectiveness and any warrant exercise.

Key Terms

auditor consent, Registration Rights Agreement, Trust Indenture Act of 1939, emerging growth company

4 terms

auditor consent financial

"as an exhibits-only filing to file an updated auditor consent as Exhibit 23.1"

Registration Rights Agreement financial

"Registration Rights Agreement by and between AEye, Inc. and Tumim Stone Capital LLC"

A registration rights agreement is a contract that gives investors the option to have their ownership stakes officially registered with the government, making it easier to sell their shares later. This agreement matters because it provides investors with a clearer path to cash out their investments if they choose, offering more liquidity and confidence in their ability to sell their holdings when desired.

Trust Indenture Act of 1939 regulatory

"Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939"

emerging growth company regulatory

"See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company”"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is AEye, Inc. (LIDR) doing in this Form S-3/A Amendment No. 1?

AEye, Inc. is filing Amendment No. 1 to its Form S-3 registration (File No. 333-296038) as an exhibits-only filing, mainly to add an updated auditor consent from KPMG LLP as Exhibit 23.1. All other parts of the registration statement remain unchanged.

What specifically changed for AEye, Inc. (LIDR) in this amendment?

The amendment adds an updated Consent of KPMG LLP as Exhibit 23.1. The company explains that the amendment consists only of the facing page, explanatory note, Part II Item 16, the signature page, the exhibit index, and the new Exhibit 23.1; the remainder is unchanged.

Does this S-3/A amendment alter the securities AEye, Inc. (LIDR) is registering?

No. AEye, Inc. states that the remainder of the registration statement is unchanged and has been omitted from this filing. The amendment only updates exhibits, particularly the auditor consent, without revising the registered securities’ terms here.

How does AEye, Inc. (LIDR) describe the effectiveness of this registration statement?

AEye, Inc. states that the registration statement’s effectiveness will be delayed until it files a further amendment specifically declaring it effective under Section 8(a) of the Securities Act, or until the SEC determines the effective date under that section.

Who signed the AEye, Inc. (LIDR) S-3/A Amendment No. 1 and in what capacity?

The amendment was signed on behalf of AEye, Inc. by Matthew Fisch, Chief Executive Officer, who is also Board Chair and a director. Other directors and the Chief Financial Officer, Conor B. Tierney, signed through Fisch acting as attorney-in-fact.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 05:17 PM Accepted by SEC EDGAR 09/11/2026 - 05:17 PM Learn about SEC filing dates

As filed with the Securities and Exchange Commission on September 11, 2026

Registration No. 333-296038

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________________________________

Amendment No. 1

to

FORM S-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

______________________________________

AEYE, INC.

(Exact name of registrant as specified in its charter)

______________________________________

Delaware	3714	37-1827430
(State or other jurisdiction of	(Primary Standard Industrial	(I.R.S. Employer
incorporation or organization)	Classification Code Number)	Identification No.)
	4670 Willow Road, Suite 125 Pleasanton, CA 94588
	(925) 400-4366

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

______________________________________

Matthew Fisch

Chief Executive Officer

4670 Willow Road, Suite 125

Pleasanton, CA 94588

(925) 400-4366

(Name, address, including zip code, and telephone number, including area code, of agent for service)

______________________________________

Copies to:

Taylor E. Landry
Allen Overy Shearman Sterling US LLP
800 Capitol Street, Suite 2200
Houston, Texas 77002
Telephone: (713) 354-4900

______________________________________

Approximate date of commencement of proposed sale to the public:
From time to time after this Registration Statement becomes effective.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐		Accelerated filer	☐
Non-accelerated filer	☒		Smaller reporting company	☒
			Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 (the “Securities Act”), as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

EXPLANATORY NOTE

AEye, Inc. is filing this Amendment No. 1 (this “Amendment”) to the Registration Statement on Form S-3 (File No. 333-296038) as an exhibits-only filing to file an updated auditor consent as Exhibit 23.1. Accordingly, this Amendment consists only of the facing page, this explanatory note, Item 16 of Part II of the Registration Statement, including the signature page and the exhibit index, and the filed Exhibit 23.1. The remainder of the Registration Statement is unchanged and has been omitted.

Part II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 16. Exhibits and Financial Statement Schedules.

(a) Exhibits.

		Incorporated by Reference
Exhibit	Description	Form	Exhibit	Filing Date
1.1*	Form of Underwriting Agreement
2.1†	Merger Agreement, dated as of February 17, 2021, by and among the Company, Merger Sub and AEye Technologies	S-4	2.1	5/13/2021
2.2†	Amendment to the Merger Agreement, dated as of April 30, 2021, by and among the Company, Merger Sub and AEye Technologies	S-4	2.2	5/13/2021
3.1	Second Amended and Restated Certificate of Incorporation of AEye, Inc.	8-K	3.1	8/23/2021
3.2	Certificate of Amendment of the Second Amended and Restated Certificate of Incorporation of AEye, Inc.	10-Q	3.2	5/11/2023
3.3	Certificate of Amendment of the Second Amended and Restated Certificate of Incorporation of AEye, Inc., as amended, filed on December 26, 2023.	8-K	3.1	12/29/2023
3.4	Amended and Restated Bylaws of AEye, Inc.	8-K	3.1	03/07/2025
4.1	Registration Rights Agreement by and between AEye, Inc. and Tumim Stone Capital LLC, dated December 8, 2021	8-K/A	4.1	12/15/2021
4.2	Registration Rights Agreement, by and between AEye, Inc. and New Circle Principal Investment LLC, dated July 25, 2024	8-K	4.1	07/29/2024
4.3	Registration Rights Agreement by and between AEye, Inc. and the purchaser named in the signature pages thereto, dated January 2, 2025	8-K	10.2	01/03/2025
4.4	Form of Senior Unsecured Convertible Promissory Note to be issued by the Company pursuant to and in accordance with the Securities Purchase Agreement, dated January 2, 2025	8-K	4.1	01/03/2025
4.5	Form of Common Stock Purchase Warrant to be issued by the Company pursuant to and in accordance with the Securities Purchase Agreement, dated January 2, 2025	8-K	4.2	01/03/2025
4.6	Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934.	10-K	4.5	03/28/2022
4.7	Warrants Agreement between AEye, Inc. and IGEP Park Place, LLC, dated May 23, 2025	S-3	4.4	08/11/2025
4.8	Warrant to Purchase Common Stock, dated August 8, 2025	S-3	4.5	08/11/2025
4.9*	Form of Certificate of Designation of Preferred Stock
4.10*	Form of Warrant Agreement and Warrant Certificate
4.11*	Form of Rights Agreement
4.12*	Form of Unit Agreement and Unit Certificate
4.13+	Form of Indenture for Senior Debt Securities
4.14+	Form of Indenture for Subordinated Debt Securities
5.1+	Opinion of Allen Overy Shearman Sterling US LLP
23.1#	Consent of KPMG LLP (with respect to AEye, Inc. financial statements)
23.2+	Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1)
24.1+	Power of Attorney (included on the signature page of the Registrant’s Registration Statement on Form S-3 filed on May 19, 2026)
25.1^	Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939 of Debt Trustee
107+	Filing Fee Table (Incorporated by reference to Exhibit 107 to the Registrant’s Registration Statement on Form S-3 filed on May 19, 2026)

† Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5), which the Registrant agrees to furnish supplementally to the SEC upon its request.

# Filed herewith.

* To be filed as an amendment or as an exhibit to a document filed under the Exchange Act and incorporated by reference into this registration statement.

^ To be filed, if necessary, separately under the electronic form type 305B2 pursuant to Section 305(B)(2) of the Trust Indenture Act of 1939, as amended.

+ Filed previously.

(b) Financial Statement Schedules.

Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.

II-1 

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, hereunto duly authorized, in Pleasanton, California, on this 11th day of September, 2026.

AEYE, INC.
By:	/s/ Matthew Fisch
Name:	Matthew Fisch
Title:	Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature			Title		Date
/s/ Matthew Fisch			Chief Executive Officer, Board Chair and Director		September 11, 2026
Matthew Fisch			(Principal Executive Officer)
*			Chief Financial Officer		September 11, 2026
Conor B. Tierney			(Principal Financial Officer and Principal Accounting Officer)
*			Director		September 11, 2026
Timothy J. Dunn
*			Director		September 11, 2026
Prof. Dr. Bernd Gottschalk
*			Director		September 11, 2026
Jonathon B. Husby
*			Director		September 11, 2026
Doron Simon
*			Director		September 11, 2026
Sue E. Zeifman
*By:	/s/Matthew Fisch
Matthew Fisch Attorney-in-fact

II-2